Skip to main content
Premium Trial:

Request an Annual Quote

Aurora Alum Thomas Klopack Appointed CEO of Aclara

NEW YORK, March 20 - Aclara Biosciences has appointed Thomas Klopack CEO, the company said today.

 

Klopack, who was COO of Aurora Biosciences from 1998 until 2002, fills a position that has gone through a bit of musical chairs in the past few months: CEO Joseph Limber left last December, and Ed Hurwitz, a board member, was appointed interim CEO at the time, then stepped down Feb. 21. The company temporarily filled the management gap by bringing back Limber and recruiting board member Andre Marion to lead the company together as "the office of the president".

 

These changes come as the company shifts from a focus on microfluidics to assays that can be run on standard sequencing equipment, Jon Miller, director of corporate development, told GenomeWeb last month.

 

Klopack managed  the operations of Aurora, and managed integration of operations after the company was acquired by PanVera in 2001, Aclara said. Klopack previously worked at Raychem from 1979 to 1998, and holds an MBA from HarvardBusinessSchoolas well as a BS in engineering from Carnegie-MellonUniversity.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.